Molecular mechanisms underlying the development of hepatocellular carcinoma

被引:44
作者
Bergsland, EK [1 ]
机构
[1] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Med, Div Hematol & Oncol, San Francisco, CA 94115 USA
关键词
D O I
10.1053/sonc.2001.26955
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:521 / 531
页数:11
相关论文
共 61 条
[21]   Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: A pilot study [J].
Ikeda, K ;
Saitoh, S ;
Kobayashi, M ;
Suzuki, Y ;
Suzuki, F ;
Tsubota, A ;
Arase, Y ;
Murashima, N ;
Chayama, K ;
Kumada, H .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (04) :406-415
[22]   The increasing incidence of hepatocellular carcinoma [J].
Ince, N ;
Wands, JR .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (10) :798-799
[23]   Improved survival with oral administration of enteric-coated tegafur/uracil for advanced stage IV-A hepatocellular carcinoma [J].
Ishikawa, T ;
Ichida, T ;
Sugitani, S ;
Tsuboi, Y ;
Genda, T ;
Sugahara, S ;
Uehara, K ;
Inayoshi, J ;
Yokoyama, J ;
Ishimoto, Y ;
Asakura, H .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2001, 16 (04) :452-459
[24]   Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection [J].
Kakumu, S ;
Ito, S ;
Ishikawa, T ;
Mita, Y ;
Tagaya, T ;
Fukuzawa, Y ;
Yoshioka, K .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 (04) :431-436
[25]   Repression of hepatitis B virus X gene expression by hammerhead ribozymes [J].
Kim, YK ;
Junn, E ;
Park, I ;
Lee, Y ;
Kang, C ;
Ahn, JK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1999, 257 (03) :759-765
[26]   Hepatitis B virus transgenic mouse model of chronic liver disease [J].
Larkin, J ;
Clayton, M ;
Sun, B ;
Perchonock, CE ;
Morgan, JL ;
Siracusa, LD ;
Michaels, FH ;
Feitelson, MA .
NATURE MEDICINE, 1999, 5 (08) :907-912
[27]   Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinoma [J].
Lee, YI ;
Lee, S ;
Das, GC ;
Park, US ;
Park, SM ;
Lee, YI .
ONCOGENE, 2000, 19 (33) :3717-3726
[28]  
Leung TWT, 1999, CLIN CANCER RES, V5, P1676
[29]   The translation initiation factor, hu-Sui1 may be a target of hepatitis B X antigen in hepatocarcinogenesis [J].
Lian, ZR ;
Pan, JB ;
Liu, J ;
Zhang, SM ;
Zhu, MH ;
Arbuthnot, P ;
Kew, M ;
Feitelson, MA .
ONCOGENE, 1999, 18 (09) :1677-1687
[30]   High frequency of p16INK4A gene alterations in hepatocellular carcinoma [J].
Liew, CT ;
Li, HM ;
Lo, KW ;
Leow, CK ;
Chan, JYH ;
Hin, LY ;
Lau, WY ;
Lai, PBS ;
Lim, BK ;
Huang, J ;
Leung, WT ;
Wu, S ;
Lee, JCK .
ONCOGENE, 1999, 18 (03) :789-795